Announcements Trials

Browse Landscape

Phase

Status

Recruiting 142 Active not recruiting 103 Completed 80 Not yet recruiting 29 Terminated 22 Withdrawn 3 Suspended 1 No longer available 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 31 Magnetic Resonance Spectroscopy 19 Biopsy 16 Cyclophosphamide 10 venetoclax 7 Nivolumab 6 Azacitidine 6 pembrolizumab 5 Vincristine 5 Etoposide 5 fludarabine phosphate 4 Surgical Procedures, Operative 4 Radiotherapy, Intensity-Modulated 4 Radiation 4 Injections 4 Doxorubicin 4 Cisplatin 4 fludarabine 3 X-Rays 3 Taxes 3 Tacrolimus 3 Surveys and Questionnaires 3 Radiosurgery 3 Prednisone 3 Leucovorin 3 Irinotecan 3 Ipilimumab 3 Fluorouracil 3 Educational Status 3 Dexamethasone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Docetaxel × 1 year × Clear all

NCT05378763 2026-05-22

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡